Skip to content

Xtant Medical Holdings XTNT Cash Flow Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$1.83M-63.3%$4.97M+184%$1.75M+138%-$4.58M+61.8%-$11.99M+27.1%
$4.68M-10.3%$5.22M+14.7%$4.55M+2.0%$4.46M+4.0%$4.29M+1.6%
$2.87M-0.4%$2.89M-3.8%$3M-14.3%$3.5M-10.3%$3.9M-3.8%
-$274K-9.2%-$251K-356%$98K-42.7%$171K-21.9%$219K-17.0%
-$596K+80.9%-$3.13M
-$692K-116%$4.2M+58.5%$2.65M+56.7%$1.69M+506%$279K+109%
$1.67M+8.3%$1.54M
$9.15M-27.0%$12.55M+75.1%$7.17M+757%$836K+115%-$5.53M+56.0%
$1.39M-41.9%$2.38M-10.4%$2.66M-38.6%$4.33M-4.4%$4.53M+10.2%
$230K-0.9%$232K-25.4%$311K+4.7%$297K-10.5%$332K-13.3%
$19.26M+144%$7.9M+198%$2.65M+166%-$4.04M+3.9%-$4.2M-12.6%
$59K-11.9%$67K0.0%$67K0.0%$67K+1.5%$66K+1.5%
$85K-65.9%$249K-61.8%
-$22.59M-121%-$10.23M-52.9%-$6.69M-252%$4.4M-59.4%$10.83M-36.0%
$232K0.0%$232K+604%-$46K
$6.72M-39.5%$11.11M
-$71K+6.6%-$76K-219%$64K+60.0%$40K+464%-$11K-120%
-$274K-9.2%-$251K-356%$98K-42.7%$171K-21.9%$219K-17.0%
$3.28M
$1.67M+8.3%$1.54M
$4.1M+10.2%$3.72M
$503K-6.3%$537K-5.5%$568K-4.2%$593K+0.5%$590K+13.0%
$17.9M+78.2%$10.05M
$230K-0.9%$232K-25.4%$311K+4.7%$297K-10.5%$332K-13.3%
$59K-11.9%$67K0.0%$67K0.0%$67K+1.5%$66K+1.5%
$127K+0.8%$126K-31.5%$184K-17.1%$222K+30.6%$170K-4.5%
$85K-65.9%$249K-61.8%
$232K0.0%$232K+604%-$46K
$7.77M-23.6%$10.16M+96.5%$5.17M+283%-$2.83M+69.9%-$9.39M+41.3%
$7.77M-23.6%$10.16M+96.5%$5.17M+283%-$2.83M+69.9%-$9.39M+41.3%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Xtant Medical Holdings generate?
Xtant Medical Holdings (XTNT) generated $9.2M in operating cash flow over the trailing twelve months.
What is Xtant Medical Holdings's free cash flow?
After $1.4M of capital expenditures, Xtant Medical Holdings's free cash flow was $7.8M over the trailing twelve months, up 182.7% year over year.
Where does Xtant Medical Holdings's cash flow data come from?
Every line is extracted from Xtant Medical Holdings's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.